Patents by Inventor Daniel Canterbury

Daniel Canterbury has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antagonists of prostaglandin EP3 receptor
    Patent number: 9738626
    Abstract: Provided herein are antagonists of prostaglandin EP3 receptor, processes to make said antagonists, and methods comprising administering said antagonists to a mammal in need thereof.
    Type: Grant
    Filed: December 16, 2015
    Date of Patent: August 22, 2017
    Assignee: Pfizer Inc.
    Inventors: Kevin Bahnck, Daniel Canterbury, David James Edmonds, Kentaro Futatsugi, Esther Cheng Yin Lee, Elnaz Menhaji-Klotz, Jana Polivkova, Robert Vernon Stanton
  • ANTAGONISTS OF PROSTAGLANDIN EP3 RECEPTOR
    Publication number: 20160176851
    Abstract: Provided herein are antagonists of prostaglandin EP3 receptor, processes to make said antagonists, and methods comprising administering said antagonists to a mammal in need thereof.
    Type: Application
    Filed: December 16, 2015
    Publication date: June 23, 2016
    Applicant: Pfizer Inc.
    Inventors: Kevin Bahnck, Daniel Canterbury, David James Edmonds, Kentaro Futatsugi, Esther Cheng Yin Lee, Elnaz Menhaji-Klotz, Jana Polivkova, Robert Vernon Stanton